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Abstract: Saliva is a readily available oral fluid
with many functions, from digestion, maintenance of
oral tissues’ integrity, to caries prevention. Changes re-
garding its secretion may be divided into qualitative
and quantitative: both of them are a consequence of
certain conditions/diseases (e.g. internal factors) or nu-
trients/drugs ingested (e.g. external factors). During
the last 15 years, technological advances gave a signif-
icant momentum to utilization of saliva as a diagnostic
tool. Analysis of saliva, just like the blood analysis, has
two main objectives: to identify the subjects suffering
from a certain disorder, and to follow the development
and progress of therapy. This paper provides an overvi-
ew of possibilities for the use of saliva for diagnostic
purposes and gives specific examples of some clinical
investigations, with the final aim to stimulate the use of
this noninvasive means for the health care promotion.
Key words: caries, diagnosis, disease, oral fluid,
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INTRODUCTION
Saliva is a complex fluid originating from three
major and several minor salivary glands, gingival cre-
vicular fluid, bacterial products, epithelial cells and
food debris (1). In addition, it contains minerals, elec-
trolytes, buffers, enzymes and their inhibitors, growth
factors, cytokines, immunoglobulins, mucin, and other
glycoproteins (2, 3). About 93% of its volume is secre-
ted by major salivary glands, while the remaining 7%
originates from minor salivary glands. The main com-
ponent of the saliva is water — 99%. Secretion of the
saliva may be influenced by numerous physiological
and pathological factors, either reversibly or irrevers-
ibly. Saliva plays an important role in maintaining the
integrity of oral cavity, as well as digestion and control
of oral infections (4). The role of saliva in caries pro-
tection may be viewed from 4 aspects: dilution and eli-
mination of sugars and other compounds, buffering ac-
tion, balance between demineralization and reminera-
lization process, and antimicrobial function. Saliva
may present an option for diagnostics of specific disor-
ders and diseases. Finally, it enables tracking of disease
pathogenesis. Although the main component of the sa-
liva is water, it plays an important role in lubrication
and reparation of oral mucosa, formation and swallow-
ing of the food bolus, and control of the oropharyngeal
microbial population.
CLINICAL IMPORTANCE
OF QUALITY AND QUANTITY
OF SALIVA IN ORAL HEALTH
MAINTENANCE
Just as much as the quantity, the quality of saliva
holds a great importance since every single component
plays a role in its various specific functions. Normal
quantity of saliva may be reduced significantly affect-
ing the individual quality of life and oral health. Lead-
ing signs and symptoms related to hyposalivation are
“dry mouth syndrome” or xerostomia, thirst, difficulty
swallowing and chewing, especially when eating dry
foods, a need to sip drinks frequently, difficulty wear-
ing dentures, mouth soreness and irritation, and burn-
ing mouth sensation.
Reduced salivary flow may be caused by many
physiological and pathological mechanisms.
Salivary gland function is naturally reduced in el-
ders. Furthermore, decreased secretion is related to the
intake of certain medications, diabetes and hyperten-
sion. More than 400 commonly prescribed drugs may
affect salivary secretion. Head and neck radiotherapy
cause irreversible destruction of the glandular paren-
chyma. Certain systemic disorders, such as some auto-
immune disorders (namely Sjögren syndrome) lead to
a progressive destruction of salivary glands, while oth-
ers cause vascular or neurological alterations showing
short or long- term repercussions on salivary secretion:
these include hypertension, depression, malnouris-
hment, dehydration and diabetes.
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Salivary secretion has its physiological peak in
the time of tooth eruption and is related to hyperstimu-
lation of peripheral receptors in oral mucosa. This
hyperstimulation may also be observed during the first
trimester of pregnancy and menstrual bleeding.
Pathological causes of hypersalivation are divided
into oral and non-oral. The former include the initial
stages of prosthetic rehabilitation with a denture, toot-
hache, irritation and/or pain in the oropharyngeal re-
gion. On the other hand, certain neurological disorders
such as Parkinson’s disease, epilepsy, encephalitis, or
some tumors, as well as exogenous toxins (bismuth,
mercury, silver, gold, arsenic or endotoxins during ure-
mia) and pilocarpine may trigger hypersalivation.
During the last 15 years, technological advances
gave a significant momentum to utilization of saliva as
a diagnostic tool. Measurement and tracking of the mo-
lecular components within the saliva, and their compa-
rison to the components of the serum enabled the anal-
ysis of microorganism, chemical and immunological
markers (5, 6). Consequently, saliva became not just an
indicator of oral health but also a powerful tool for me-
asuring basic indicators of overall health. Nowadays,
there is a growing interest for investigations regarding
the use of saliva for diagnostic purposes. Analysis of
saliva, just like the blood analysis, has two main objec-
tives: to identify the subjects suffering from a certain
disease, and to follow the development and progress of
therapy. Advantages of using the saliva as a diagnostic
medium compared to the blood are simple and non-in-
vasive sampling procedure (devoid of stress or risks)
easily acceptable for the patient, low cost, and use for
investigation purposes. One of the most important ad-
vantages for using the saliva as a diagnostic tool is its
simple, non-invasive sampling process.
Various components within the saliva, besides
protecting tissue integrity, enable detection of local
and systemic conditions and diseases. Saliva is especi-
ally useful for qualitative diagnostics and detection of
certain markers in numerous diseases, such as viral in-
fections (HIV, hepatitis), some hereditary diseases
(cystic fibrosis), autoimmune disorders (Sjögren syn-
drome), and malignancies. For example, p53 is known
as a tumor suppressor protein and antibodies targeted
against it have been detected in patients with squamous
cellular carcinoma in the oral cavity, thus helping the
early detection and monitoring of this disease (7, 8).
There are several reports describing possible uses
of salivary creatinine levels in detection of renal disea-
ses (9, 10, 11).
Saliva also represents a useful medium for diag-
nosis of certain oral diseases, and monitoring of drug
and hormone levels. Specific salivary tests for antibod-
ies (anti-viral and anti-bacterial), steroid hormones (es-
trogen, progesterone and testosterone), exogenous tox-
ins (cadmium and mercury), tobacco and some drugs
(ethanol, lithium) have a sufficient sensitivity to reflect
their blood levels (12). Qualitative changes in its com-
position provide necessary information related to diag-
nostics of certain oral diseases. Namely, increased al-
bumin levels in whole saliva were demonstrated in pa-
tients on chemotherapy who developed stomatitis later
on, posing as a significant marker for future prognosis
of this complication (13). Increased levels of salivary
nitrates and nitrites, and reduced activity of nitrate re-
ductase were detected in patients with oral carcinoma
when compared to healthy subjects.
Detection of increased numbers of certain bacte-
rial species in the saliva is related to increased possibil-
ity of caries development, especially on the root surfa-
ce (4).
Saliva may be collected with or without stimula-
tion; one of the best methods for unstimulated saliva
collection is passive drool into the measuring sterile
vial (14). Collection of stimulated saliva is performed
following chewing or stimulation of taste buds.
One of the most common methods used in rese-
arch is collection of the whole unstimulated saliva
(WUS) which represents the pool of saliva from all —
major and minor- salivary glands.
Although WUS represents both local and systemic
pathophysiological states in the moment of saliva col-
lection, some factors such as hyposalivation in elders,
use of certain drugs, periodontitis, fear and anxiety may
affect the results obtained during such research.
Due to the relationship between oral and overall
health, clinicians mostly use saliva as diagnostic me-
ans, although it is still debated that we could profit
even more from such analyses (15, 16).
In the past, mostly used diagnostic means was
blood serum, however saliva holds many advantages
over both serum and urine (2).
Saliva is readily collected during clinical or labo-
ratory work in quantities sufficient for various tests.
These tests hold certain advantages over serum analy-
sis since saliva collection is non-invasive, therefore
preventing fear, uneasiness and anxiety which patients
feel when involved in other analyses.
Cytokines play role in pathogenesis of numerous
oral diseases such as bacterial, viral and fungal infecti-
ons, as well during the pathogenesis of immunological
disorders of the oral cavity and development of precan-
cerous lesions.
Research demonstrated a significant increase in
the levels of interleukin-6 (IL-6) and interleukin-2
(IL-2) in the saliva of patients with Sjögren syndrome
and decreased levels of IL-2 in patients under treat-
ment with pilocarpine (17).
Saliva of HIV-positive patients with oral candidi-
asis holds elevated values of interferon gamma (IFN-)
compared to other HIV-positive patients with healthy
mouth and otherwise healthy controls. In addition, in-
creased values of IFN- were found in saliva of
HIV-positive patients with oral villous leukoplakia,
compared to HIV-positive patients without pathologi-
cal oral findings (18).
Saliva of patients suffering from recurrent aphtho-
us ulcerations which developed as a consequence of
destructive autoimmune reaction reportedly has decre-
ased values of vascular endothelial growth factor
(VEGF) — the cytokine which plays a role in angioge-
nesis and healing (19).
In our previous researches we predominantly used
saliva for the purpose of cytokine detection in particu-
lar oral diseases. In patients with oral lichen planus
(OLP), we tested the levels of salivary tumor necrosis
factor-alpha (TNF-). This study was undertaken to
quantify the salivary levels of pro-inflammatory mar-
ker in the reticular and the erosive/atrophic forms of
OLP, compared with age-matched healthy control vol-
unteers. Whole saliva from 40 patients with active lesi-
ons of OLP, as well as from 20 healthy persons, was in-
vestigated for the presence of TNF- by enzyme im-
munoassay. Salivary TNF- levels were significantly
increased in patients with OLP in comparison with he-
althy subjects. The presence of TNF- showed positi-
ve correlation to clinical forms of OLP, being signifi-
cantly higher in the erosive/atrophic type than in the re-
ticular type of disease. Saliva provides an ideal medi-
um for the detection of pro-inflammatory markers of the
oral cavity. In patients with OLP, TNF- levels in saliva
were elevated, correlating with the severity of illness.
Salivary TNF- analysis may be a useful diagnostic tool
and a potential prognostic marker in OLP (20).
Since burning mouth syndrome (BMS) is quite
common diagnosis in the field of oral medicine, and ta-
king into account painful symptoms in many patients
who do not express any clinical changes on the oral
mucosa, we have undertaken a study focusing on sali-
vary levels of IL-2 and IL-6. Affected patients often
presented multiple oral complaints, including burning,
dryness, and taste alterations. The etiology of BMS is
still unknown. Role of various cytokines has been im-
plicated in the development of BMS. The aim of this
study was to evaluate levels of salivary IL-2 and IL-6
in patients with BMS, compared with age-matched he-
althy volunteers (control group). Whole saliva from 30
patients with BMS, age range 55 5, was tested for the
presence of IL-2 and IL-6 by enzyme immunoassay.
Control group consisted of 30 healthy participants,
aged 55 5 years. Saliva IL-2 concentrations in BMS
were significantly increased in patients compared to
healthy subjects: mean 34.1 9.7 versus 7.3 3.0 pg/mL;
P < .001. Patients with BMS had significantly higher
concentrations of IL-6 compared to control: mean 30.8
5.6 versus 5.2 2.8 pg/mL; P < .001. In patients with
BMS, IL-2 and IL-6 levels in saliva were elevated, cor-
relating with the severity of illness (21).
In yet another study we compared the levels of
proinflammatory cytokines in patients with burning
mouth syndrome before and after low level laser ther-
apy (LLLT) (22). The aim of this study was to determi-
ne the levels of proinflammatory cytokines TNF- and
IL-6 in WUS in subjects with BMS before and after tre-
atment with LLLT. BMS is characterized by a continu-
ous, painful burning sensation in a clinically nor-
mal-appearing oral mucosa. A sample consisting of 40
consecutive subjects was selected on a voluntary basis
from the pool of patients who presented for diagnosis
and treatment of BMS. For determination of salivary
levels of TNF- and IL-6, an enzyme-linked immuno-
sorbent assay (ELISA) was performed. After 4 weeks
of LLLT, the salivary levels of TNF- and IL-6 in the
experimental group decreased significantly (p < 0.001).
There was no significant difference in the experimental
group regarding visual analogue scale.
Regarding quite frequent questions on negative
effects of amalgam fillings and their possible influence
on pathological changes on the oral mucosa, we ran a
research on correlation between oral lichenoid reaction
and amalgam fillings. The aim of this study was to per-
form a clinical assessment of the association between
oral lichenoid reactions (OLR) and amalgam restorati-
ons and to determine the salivary concentrations of
IL-6 and IL-8 before and after replacement of the amal-
gam restorations. The study included 20 patients with
OLR and 20 healthy volunteers. All patients were skin
patch tested by an experienced physician. Saliva sam-
ples were collected, prepared and analyzed for IL-6
and IL-8 concentrations using enzyme-linked immu-
nosorbent assay. Sixteen out of 20 patch-tested patients
showed a sensitization to inorganic mercury or amal-
gam. Total replacement of all amalgam fillings was
carried out on 20 patients with fillings based on com-
posite resin, gold, porcelain or a combination of these.
Sixteen out of 20 patients showed complete healing of
OLR; three patients had marked improvement, where-
as one patient showed no improvement. Levels of IL-6
detected before replacement were significantly higher
than IL-6 levels following the replacement (P = 0.003).
The IL-8 levels measured before replacement procedu-
re were significantly higher than the IL-8 levels after
replacement of the fillings (P < 0.001).On the basis of
clinical observations, restorative therapy resulted in
tissue healing. Following the replacement of amalgam
fillings with fillings based on other restorative materi-
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als, levels of both IL-6 and IL-8 shifted towards nor-
mal, as measured in healthy subjects (23).
In order to prove the efficacy of the biostimulative
laser therapy, we ran a research correlating the clinical
signs to biostimulative therapy and levels of TNF-
and IL-6. The aim of this study was to monitor therape-
utic response by determining the levels of proinflam-
matory cytokines TNF- and IL-6 in whole unstimula-
ted saliva in patients with denture stomatitis (DS), be-
fore and after laser therapy. DS is an inflammatory
condition that occurs in subjects who wear dentures
(usually upper), and it is a common oral mucosal le-
sion. A potential noninvasive treatment for DS patients
is laser phothotherapy. A group of 40 consecutive sub-
jects was selected on the voluntary basis from the pool
of patients who presented for the diagnostics and treat-
ment of DS. A clinical examination was performed ac-
cording to the standard clinical criteria. Lesions descri-
bed as palatal inflammation were diagnosed as Newton
type II denture stomatitis. The patients were randomly
assigned to either an experimental group (20 patients
receiving the real LPT) or a control group (20 patients
receiving inactive/placebo laser treatment). In order to
determine the salivary levels of TNF-á and IL-6, ELI-
SA testing was performed. Following treatment with
LPT for 4 weeks, the levels of TNF- and IL-6 decrea-
sed significantly (p < 0.001) and were significantly dif-
ferent from controls (p < 0.001).The results of this
study suggest that LPT may be an effective choice of
therapy (24).
CONCLUSION
During the past 10 years we ran several investigati-
ons where we used saliva as a diagnostic tool, and con-
sequently we have proved that it may be regarded as the
perfect medium to be explored for health and disease
monitoring. The translational applications and opportu-
nities are enormous. The ability to monitor health status,
disease onset and progression, and treatment outcome
through noninvasive means is the most desirable goal in
the health care promotion and delivery.
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Sa`etak
SALIVA KAO DIJAGNOSTI^KI MATERIJAL
Pezelj-Ribaric Sonja, Prpic Jelena, Glazar Irena
Department of Oral Medicine and Periodontology, Clinical Hospital Centre, Faculty of Medicine, University of Rijeka, Croatia
Pljuva~ka je dostupna oralna te~nost sa brojnim
funkcijama, od varenja, preko odr`avanja integriteta tki-
va, do prevencije karijesa. Promene koje se odnose na se-
kreciju pljuva~ke mogu biti kvalitativne i kvantitativne:
obe promene su posledica odre|enih stanja/bolesti (unu-
tra{njih faktora) ili hranljivih materija/lekova unetih u or-
ganizam (spolja{nji faktori). U poslednjih 15 godina, na-
preci u oblasti tehnologije dali su veliki doprinos kori{}e-
nju pljuva~ke u dijagnosti~ke svrhe. Analiza pljuva~ke,
kao i analiza krvi, ima dva glavna cilja: da identifikuje
supstance organizma koji trpe zbog odre|ene bolesti, i da
prate napredak i terapijski u~inak. Ovaj rad obezbe|uje
pregled mogu}nosti koje pru`a kori{}enje salive u dijag-
nosti~ke svrhe i daje primere odre|enih klini~kih istra`i-
vanja, sa glavnim ciljem da stimuli{e kori{}enje ovog ne-
invazivnog sredstva u unapre|enju zdravlja populacije.
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